Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,003 | 63 | 97.4% |
| Education | $26.33 | 2 | 2.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $191.60 | 14 | $0 (2023) |
| ABBVIE INC. | $121.89 | 5 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $84.98 | 5 | $0 (2020) |
| GlaxoSmithKline, LLC. | $76.44 | 5 | $0 (2023) |
| Abbott Laboratories | $66.65 | 3 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $61.09 | 4 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $59.22 | 4 | $0 (2020) |
| Astellas Pharma US Inc | $51.57 | 3 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $48.99 | 4 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $40.17 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $73.54 | 4 | Astellas Pharma US Inc ($37.35) |
| 2023 | $71.32 | 4 | AbbVie Inc. ($21.20) |
| 2022 | $208.30 | 10 | ABBVIE INC. ($83.21) |
| 2020 | $70.11 | 5 | Novo Nordisk Inc ($17.10) |
| 2019 | $514.01 | 36 | Novo Nordisk Inc ($147.32) |
| 2018 | $74.19 | 5 | Endo Pharmaceuticals Inc. ($18.02) |
| 2017 | $18.35 | 1 | GlaxoSmithKline, LLC. ($18.35) |
All Payment Transactions
65 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/25/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: Endocrinology | ||||||
| 06/04/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: Biological | ||||||
| 05/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: NEUROSCIENCE | ||||||
| 04/04/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Biological | ||||||
| 05/25/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/16/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: NEUROSCIENCE | ||||||
| 04/13/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BEXSERO, PEDIARIX | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: VACCINES | ||||||
| 03/02/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Diabetes | ||||||
| 12/16/2022 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: Diabetes Care | ||||||
| 11/29/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $29.68 | General |
| Category: NEUROSCIENCE | ||||||
| 11/09/2022 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: Diabetes Care | ||||||
| 10/25/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: NEUROSCIENCE | ||||||
| 10/19/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $31.97 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.00 | General |
| 07/11/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: Diabetes Care | ||||||
| 06/12/2022 | Lilly USA, LLC | — | Education | In-kind items and services | $11.71 | General |
| 06/02/2022 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Endocrinology | ||||||
| 05/03/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $11.95 | General |
| Category: Diabetes | ||||||
| 03/02/2020 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological), VAQTA, GARDASIL 9 | Food and Beverage | In-kind items and services | $12.58 | General |
| Category: VACCINE | ||||||
| 02/27/2020 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: Endocrinology | ||||||
| 02/10/2020 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: Diabetes | ||||||
| 02/06/2020 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), XARELTO | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/22/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/16/2019 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Diabetes | ||||||
| 11/14/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 312 | 361 | $47,918 | $19,056 |
| 2022 | 9 | 370 | 474 | $45,645 | $19,351 |
| 2021 | 13 | 421 | 552 | $56,972 | $24,303 |
| 2020 | 12 | 416 | 530 | $61,164 | $25,844 |
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 72 | 87 | $18,976 | $7,139 | 37.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 28 | 28 | $7,019 | $3,431 | 48.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 24 | 45 | $6,975 | $2,737 | 39.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 34 | 35 | $5,232 | $1,938 | 37.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 15 | 15 | $3,345 | $1,332 | 39.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 11 | 11 | $3,124 | $1,116 | 35.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 72 | 84 | $1,596 | $689.66 | 43.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 11 | 11 | $484.00 | $296.63 | 61.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 22 | 22 | $638.00 | $209.44 | 32.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 23 | 23 | $529.00 | $168.55 | 31.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 75 | 88 | $16,984 | $7,243 | 42.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 39 | 39 | $8,931 | $4,876 | 54.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 51 | 57 | $7,410 | $3,267 | 44.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 18 | 45 | $6,345 | $2,472 | 39.0% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 31 | 41 | $1,189 | $393.67 | 33.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 84 | 129 | $2,451 | $382.20 | 15.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 37 | 40 | $920.00 | $307.12 | 33.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 20 | 20 | $740.00 | $209.92 | 28.4% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 15 | 15 | $675.00 | $199.92 | 29.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 70 | 92 | $17,296 | $7,425 | 42.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 36 | 36 | $8,244 | $4,509 | 54.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 19 | 41 | $8,323 | $3,150 | 37.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 22 | 49 | $6,909 | $2,656 | 38.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 38 | 39 | $4,992 | $2,081 | 41.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 12 | 12 | $3,036 | $1,410 | 46.4% |
About Dr. Amy Bailey, M.D
Dr. Amy Bailey, M.D is a Family Medicine healthcare provider based in Dacula, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/08/2007. The National Provider Identifier (NPI) number assigned to this provider is 1275731580.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amy Bailey, M.D has received a total of $1,030 in payments from pharmaceutical and medical device companies, with $73.54 received in 2024. These payments were reported across 65 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,003).
As a Medicare-enrolled provider, Bailey has provided services to 1,519 Medicare beneficiaries, totaling 1,917 services with total Medicare billing of $88,554. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Dacula, GA
- Active Since 07/08/2007
- Last Updated 10/06/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1275731580
Products in Payments
- Ozempic (Drug) $90.38
- UBRELVY (Drug) $83.21
- INVOKANA (Drug) $59.22
- SOLIQUA 100/33 (Drug) $52.18
- Trintellix (Drug) $46.89
- Tresiba (Drug) $46.67
- FREESTYLE LIBRE (Device) $42.28
- FARXIGA (Drug) $40.17
- Dexcom G6 Transmitter (Medical Supply) $38.49
- Veozah (Drug) $37.35
- JANUVIA (Drug) $36.41
- Aimovig (Biological) $35.52
- SHINGRIX (Biological) $30.46
- ANORO (Drug) $27.63
- Saxenda (Drug) $27.37
- Rybelsus (Drug) $27.18
- FREESTYLE LIBRE 2 (Device) $24.37
- QULIPTA (Drug) $21.20
- TOUJEO (Drug) $19.45
- ADVAIR (Drug) $18.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Dacula
Dr. Inchol Yun
Family Medicine — Payments: $15,022
Sumathi Puttu, Md, MD
Family Medicine — Payments: $10,611
Dr. Carla Price, M.d, M.D
Family Medicine — Payments: $4,635
Rene Latoni, Md, MD
Family Medicine — Payments: $2,065
David Najjar, M.d, M.D
Family Medicine — Payments: $1,859
Henry Moon, Md, MD
Family Medicine — Payments: $1,754